Usa Europe Coronavirus Johnson & Johnson Usa

EMA: Benefits of J&J Covid-19 vaccine outweigh risks

Reading now: 965
www.rte.ie

The European Medicines Agency has said the benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks. Use of the company's one-dose vaccine was temporarily halted by US regulators last week after a small number of blood clots were reported. More to follow... Latest coronavirus stories

Read more on rte.ie
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA